(Q24247701)

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Continuous nebulization of albuterol (salbutamol) in acute asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Randomised pragmatic comparison of UK and US treatment of acute asthma presenting to hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Continuous versus intermittent albuterol nebulization in the treatment of acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Continuous vs intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Comparative trial of continuous nebulization versus metered-dose inhaler in the treatment of acute bronchospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Frequency of inhaled metaproterenol in the treatment of acute asthma exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

The efficacy and safety of a continuous albuterol protocol for the treatment of acute adult asthma attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

A randomized, controlled double-blind trial of usual-dose versus high-dose albuterol via continuous nebulization in patients with acute bronchospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Continuous vs intermittent beta-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Corticosteroids for preventing relapse following acute exacerbations of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Intravenous beta2-agonists for acute asthma in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

The health economics of asthma and rhinitis. I. Assessing the economic impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

Improvement in clinical asthma score and PaCO2 in children with severe asthma treated with continuously nebulized terbutaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

inferred from DOI database lookup

7 January 2021

based on heuristic

A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115

inferred from DOI database lookup

7 January 2021

based on heuristic

Continuous vs intermittent nebulized albuterol for emergency management of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001115